Core Scientific Creations

Company Overview

Snapshot

Founded in October 2012 by Damian Delfino and Yuval Yaskil, Core Scientific Creations operates with 11–50 employees. The company specializes in medical devices for advanced bleeding control, notably its WoundClot product, which has achieved global sales.

Business overview

Core Scientific Creations develops and manufactures medical devices focused on advanced bleeding control, primarily through its WoundClot product. This non-oxidized cellulose hemostat is engineered to manage various types of bleeding, including non-compressional mild, moderate, and severe hemorrhages, in both inpatient and outpatient settings. The technology serves markets such as hospitals, home care, surgery, military, dental, and veterinary applications, operating within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics.

Strategic signal

In February 2018, Core Scientific Creations' Israeli-developed WoundClot bandage, designed to stop bleeding within seconds, achieved global sales. This expansion indicates strong market validation and commercial traction for the company's core product, signaling its potential for widespread adoption in critical medical and emergency care scenarios.

Company Intelligence Q&A

What is Core Scientific Creations' primary product?

Core Scientific Creations' primary product is WoundClot, a non-oxidized cellulose hemostat designed to control various types of bleeding quickly and safely.

When was Core Scientific Creations founded?

Core Scientific Creations was founded in October 2012.

Which markets does Core Scientific Creations serve?

Core Scientific Creations serves markets including hospitals, home care, surgery, military, dental, and veterinary applications with its bleeding control solutions.

What is a key feature of the WoundClot product?

WoundClot creates a biological clot that is fully absorbed by the body within seven days and promotes coagulation for coagulopathic patients, making it suitable for severe arterial bleeding.

Has Core Scientific Creations' product achieved international distribution?

Yes, in February 2018, the Israeli-developed WoundClot bandage was reported to be sold globally, indicating international market penetration.